Selected cases

High Court of Australia · [2023] HCA 8

Priority

Self Care IP Holdings v Allergan

This decision matters to brand owners because it considered trade mark use, product get-up and misleading or deceptive conduct in a commercial product context.

High Court of Australia15 Mar 2023

These are plain-English explainers, not legal advice. They are a good starting point, but check the linked official source before you rely on a specific section, and get advice for your situation.

Talk to a lawyer

Decision snapshot

Facts

The dispute

Allergan owned rights associated with BOTOX. Self Care sold anti-wrinkle skincare products including Freezeframe INHIBOX and PROTOX, and used phrases such as "instant Botox alternative" in marketing. Allergan alleged that the product names and marketing crossed the line into trade mark infringement and misleading or deceptive conduct.

Issue

The legal question

The Court had to decide whether "instant Botox alternative" was being used as a trade mark, whether PROTOX was deceptively similar to BOTOX, and whether the marketing conveyed a misleading representation about the duration or nature of the wrinkle-reducing effects.

Outcome

Decision

The High Court found against the key trade mark and consumer law claims. In broad terms, the Court did not accept that the challenged words were being used in the infringing way alleged, or that the relevant misleading representation was conveyed to reasonable consumers.

Practical impact

Commercial note

Brand strategy should be checked before launch. Businesses need to consider registered marks, packaging, product naming and the overall impression created for customers.

  • Trade mark 'use' is assessed by how consumers actually perceive a sign, not just whether words appear on packaging.
  • Clearing a brand before launch, including name, get-up and comparative references, is cheaper than litigating later.
  • Consumer law and trade mark claims often run together in brand disputes; consider both.

Brand risk in context

Self Care v Allergan sits at the point where trade marks, packaging and consumer law all meet. The dispute was not just about whether two names looked similar. It was about how consumers would read a product name, comparison phrase, packaging and marketing message in context.

That makes it a useful launch-risk case. A founder may want a name that signals what the product does, references a better-known category, or makes a bold comparison. The legal question is whether the whole presentation stays clear, distinctive and accurate.

The dispute

The dispute involved anti-wrinkle products and references associated with Botox. Allergan alleged trade mark infringement and misleading or deceptive conduct. The challenged materials included the phrase "instant Botox alternative" and the name "PROTOX".

The High Court considered whether those words were being used as trade marks, whether they were deceptively similar to the registered marks, and whether the marketing conveyed the alleged misleading message about product effects.

IssueWhat it means in practice
Use as a trade markIs the sign acting as a badge of origin, or is it being used descriptively or comparatively?
Deceptive similarityWould ordinary consumers be caused to wonder whether the products came from the same source?
Misleading conductWhat representation does the whole marketing context actually convey?

What to check before launching a brand or campaign

Quick checklist

0/5

Takeaways

Key Takeaways

  • A trade mark dispute often becomes a consumer law dispute at the same time.
  • The safest brand launch reviews the whole customer impression, not just the exact words.
  • Competitor references need a clear purpose and careful execution.
  • Registering a business name is not the same as owning a trade mark.

Common questions

Can I reference a competitor's brand in my marketing?

Sometimes, but it's high-risk. Comparative references can cross into trade mark infringement or misleading conduct depending on how consumers read them, so get advice first.

Does this make trade marks weaker?

No. It clarifies how courts assess 'use as a trade mark' and consumer perception, which makes careful brand clearance and registration more important, not less.

Related topics

How Sprintlaw can help